Search results
Results From The WOW.Com Content Network
Regulation (EU) 2017/745 is a regulation of the European Union on the clinical investigation and placing on the market of medical devices for human use. It repealed Directive 93/42/EEC on Medical Devices (MDD) and Directive 90/385/EEC on active implantable medical devices (AIMDD).
Directive EU 2017/745 Repealed The Medical Device Directive — Council Directive 93/42/EEC of 14 June 1993 concerning medical devices —is intended to harmonise the laws relating to medical devices within the European Union .
Commission Implementing Regulation (EU) 2020/1207 of 19 August 2020 laying down rules for the application of Regulation (EU) 2017/745 of the European Parliament and of the Council as regards common specifications for the reprocessing of single-use devices (Text with EEA relevance) Image title: Author: www.legislation.gov.uk: Software used: FOP 1.0
Download as PDF; Printable version; In other projects Wikidata item; Appearance. move to sidebar hide ... Regulation (EU) 2017/745 in the European Union;
Download as PDF; Printable version; In other projects Wikidata item; ... Regulation (EU) 2017/745; Regulation (EU) 2017/746; Regulatory affairs; S. Substance-based ...
Substance-based medical devices encompass a varied array of products that fall under the purview of Regulation (EU) 2017/745 (MDR). Based on their intended purpose, they are classified according to rule 21 ("Devices composed of substances that are introduced via a body orifice or applied to the skin") of Annex VIII of the MDR .
Regulation (EU) 2017/745; Regulation (EU) 2017/746; Regulation (EU) 2019/1020; Regulation (EU) 2023/988; Regulation (EU) No 1169/2011; Regulation of ESG rating in the European Union; Regulation of pesticides in the European Union; Regulation on Wholesale Energy Market Integrity and Transparency; Regulation to Prevent and Combat Child Sexual ...
Under the General Product Safety Regulation (GPSR) — Regulation (EU) 2023/988 — products marketed in the EU must include an Authorized Representative if the manufacturer is located outside the European Union, starting from the 13th of December, 2024. This representative acts as a contact point for competent authorities in EU member states ...